BlackBerry's stock (BBRY) slumped 4.7% in premarket trade Wednesday, after Morgan Stanley analyst James Faucette downgraded the smartphone maker because he believes the market has become too optimistic about the company's ability to meet software sales targets.
These Studies and Genomic Health's First Liquid Biopsy Study in Bladder Cancer To Be Presented at 2014 Society of Urologic Oncology Annual Meeting, December 3-5
Authors: Isabell Sesterhenn , Timothy Brand , Inger Rosner , Joel Moncur , Amina Ali , Yongmei Chen , Nan Zhang , Athanasios Tsiatis , Dejan Knezevic , Tara Maddala , H.
Sign-up for Results from Second Oncotype DX® Prostate Cancer Test Clinical Validation and First Decision Impact Study To Be Published in European Urology and Urology Practice, Respectively investment picks
SanDisk Corporation (NASDAQ: SNDK ),
a global leader in flash storage solutions, today announced that the
company’s venture arm, SanDisk
Ventures , has invested in Altair
Semiconductor , the leading developer of high-performance,
single-mode LTE chipsets.
Marvell's ARMADA Mobile PXA1802 5-mode 4G LTE modem is at the core of Meizu's Flagship MX4 Pro Premium Smartphone, now available for more than one billion of combined subscribers of China Mobile and China Unicom
SANTA CLARA, Calif.
CareView Communications, Inc. ("CareView" or the "Company") (OTCQB:
CRVW), an information technology provider to the healthcare industry,
announced today the execution of a two-year hospital contract with
Gerald Champion Regional Medical Center in Alamogordo, New Mexico.
MILPITAS, CA --
Moelis & Company (NYSE:MC), a leading global independent investment
bank, today announced that Ken Moelis, Chairman and Chief Executive
Officer, is scheduled to present at the Goldman Sachs US Emerging/SMID
Cap Growth Conference on Thursday, November 20, 2014 at 9:30 a.m.
Kofax® Limited (NASDAQ: KFX)(LSE: KFX), a leading provider of smart
process applications for the business critical First Mile™ of customer
interactions, today reported it was issued three new patents by the
United States Patent and Trademark Office (USPTO). The Company now has
54 issued patents and 60 pending applications, with 47 percent of the
total relating to mobile imaging technologies.
Sign-up for CombiMatrix Promotes Karine Hovanes, Ph.D., to Vice President of Scientific Advancement and Laboratory Director, and Trilochan Sahoo, M.D., to Vice President of Clinical Affairs and Director of Cytogenetics investment picks
- Statistically significant and robust reductions in key biomarkers of ventricular remodeling and inflammation following single, two-hour infusion - New data consistent with previously announced improvements in left ventricular systolic function and suppression of biomarkers highly correlated with poor clinical outcomes
SAN DIEGO , Nov.
GE Healthcare, a leader in technology innovation, today announced it
will resell Caradigm’s Single Sign-On and Context Management solutions
in the United States, Canada, and specific EU countries to provide
connectivity between the Omnyx™ digital pathology platforms and
designated Anatomic Pathology Laboratory Information Systems (APLIS).
When pathologists diagnose cancers, they evaluate tissue in the context
of a patient’s history, order more tests on the tissue if necessary, and
deliver their findings to an oncologist*. The oncologist then uses the
pathologist’s report to determine the course of treatment.
Sign-up for Notice Regarding UBIC's Cessation of Issuance of New Shares (Second Round Allocation) Through A Third-party Allocation of Shares and Withdrawal of Securities Registration Statement for the Second Issuance of Shares investment picks
Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) today announced positive
top-line results from a phase 2 trial assessing safety, efficacy and
dose-response of three different once-daily oral SP-333 tablets (1.0,
3.0 and 6.0 mg) compared with placebo in 289 patients with
opioid-induced constipation (OIC). Preliminary analysis of the data
indicates SP-333 met the study’s primary endpoint and demonstrated
statistically significant improvement in mean change from baseline in
the number of spontaneous bowel movements (SBMs) during Week 4 of the
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.